Op-T-Mune was founded to commercialize the intellectual property of Dr. David Wagner, Associate Professor at the University of Colorado Denver. Dr. Wagner has developed a unique means to control autoimmune inflammation, specifically in type 1 diabetes and multiple sclerosis. In addition Dr. Wagner has developed a means to identify the pathogenic cells in those diseases that is being developed as a diagnostic tool.